抗体

HSP90AA1(热休克蛋白HSP 90甲)

030309

100微升

502美元

单克隆

小鼠

未共轭

13B387

HSP90AA1(热休克蛋白HSP 90甲)

小鼠

单克隆抗体

抗体

100微升

502美元

13B387

IgG1

HSP90 proteins are highly conserved molecular chaperones that have key roles in signal transduction, protein folding, protein degradation, and morphologic evolution. HSP90 proteins normally associate with other cochaperones and play important roles in folding newly synthesized proteins or stabilizing and refolding denatured proteins after stress. There are 2 major cytosolic HSP90 proteins, HSP90AA1, an inducible form, and HSP90AB1 (MIM 140572), a constitutive form. Other HSP90 proteins are found in endoplasmic reticulum (HSP90B1; MIM 191175) and mitochondria (TRAP1; MIM 606219) (Chen et al., 2005 [PubMed 16269234]). Applications: Western Bloting: 1:500-1:2000. Immunohistochemistry: 1:200-1:1000. Flow cytometry: 1:200-1:400. ELISA: Suggested dilution 1:10000. Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Hu Mk Mo

HSPN;LAP2;HSP86;HSPC1;HSPCA;Hsp89;Hsp90;HSP89A;HSP90A;HSP90N;HSPCAL1;HSPCAL4

纯化重组片段对应于人HSP90AA1在大肠杆菌中表达

Human, Mouse, Monkey

纯化

Purified antibody in PBS with 0.05% sodium azide and 0.5% protein stabilizer.

~1毫克/毫升

Product Type: Mab Isotype: IgG1 Clone No: 13B387 Host: mouse Source: human Concentration: ~1mg/ml Form: Purified antibody in PBS with 0.05% sodium azide and 0.5% protein stabilizer. Purity: Purified Immunogen: Purified recombinant fragment of human HSP90AA1 expressed in E. coli. Specificity: Human, Mouse, Monkey Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications without the expressed written authorization of United States Biological.

E FC免疫组化免疫印迹

-20°C

Mol Biol Cell. 2010 May 1;21(9):1462-9. Mol Cancer Ther. 2009 Dec;8(12):3296-306.